MedPath

Study of an Expandable Interbody Device for the Lumbar Spine

Not Applicable
Completed
Conditions
Degenerative Disc Disease
Interventions
Device: CALIBER
Registration Number
NCT02075554
Lead Sponsor
Globus Medical Inc
Brief Summary

The primary objective of this study is to evaluate the safety and efficacy of CALIBER expandable spacer for the treatment of degenerative disc disease. Radiographic outcomes, intra-operative parameters, clinical outcomes, and patient satisfaction will be obtained from patients in this 2 year follow-up clinical study.

Detailed Description

Patients will be followed-up at 3weeks, 6 weeks, 3 months, 6 months, 12 and 24 months with X-rays and questionnaires to determine their satisfaction, healing, fusion and return to work status

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • DDD at 1 or 2 levels between L2 and S1
  • Between 18 and 80 years of age
  • Unresponsiveness to documented non-surgical treatment modalities for a minimum of six months
  • Ability to provide a signed Informed Consent
Exclusion Criteria
  • Trauma at level(s) to be fused
  • Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
  • Immunosuppressive disorder
  • History of substance abuse
  • Any known allergy to a metal alloy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CALIBERCALIBER1 or 2 levels of DDD between L2 and S1, treated with transforaminal interbody fusion
Primary Outcome Measures
NameTimeMethod
Fusion and Disc Height Maintenance24 months

Inter-vertebral disc height in millimetres at 24 month follow up.

Fusion Assessment24 months

An assessment of the fusion status of surgically treated spinal levels.

Secondary Outcome Measures
NameTimeMethod
Patient Self AssessmentUpto 24 mo

Oswestry Disability Index. A 10 item questionnaire with responses scored 0 to 5 and then presented as a percentage score from 0 to 100, with higher scores denoting more disability.

Visual Analog Scale for Back Pain24 months

A visual scale from 0 to 100 in which the patient responds with their pain level by marking on the line, higher as more severe pain.

Trial Locations

Locations (2)

Carolina NeuroSurgery and Spine Associates

🇺🇸

Charlotte, North Carolina, United States

South Florida Spine Institute at Mt Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath